Mingyan E.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mingyan E. has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
Jiayin Liu
Harbin Medical University Cancer Hospital
4 shared publications- Manru Shi
Department of Radiation Oncology Harbin Medical University Cancer Hospital Harbin Heilongjiang Province China
3 shared publications Quan Lin
Harbin Medical University Cancer Hospital
3 shared publicationsDi Sun
Harbin Medical University Cancer Hospital
2 shared publicationsManru Shi
Department of Radiation Oncology, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Nangang District, Harbin, Heilongjiang Province, 150081, China
2 shared publications- Shaohong Fang
Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China
2 shared publications
Latest Publications
- 13 November 2026
- Published by Wiley in British Journal of Pharmacology
Mitochondrial DNA‐cGAS‐STING induces macrophage pyroptosis via phospho‐IRF3‐mediated NLRP3 expression in ionising radiation‐induced atherosclerosis progression
Background and Purpose: Ionising radiation (IR) is a major cancer‐treatment modality, yet the mechanisms driving IR‐triggered cardiovascular injury are poorly defined. This work aimed to uncover how IR accelerates atherosclerosis (AS) and the underlying molecular mechanisms. Experimental Approach: We applied 9.4 T magnetic resonance imaging to evaluate atherosclerotic lesions. Single‐cell RNA sequencing was performed on carotid arteries. Apolipoprotein E (ApoE) knockout mice with caspase‐1 deletion and macrophage‐specific cGAS knockdown were used for in vivo validation. JASPAR prediction and dual‐luciferase reporter assays were implemented to verify transcriptional regulation of NLRP3. Key Results: IR substantially aggravated atherosclerotic progression, accompanied by elevated pyroptosis‐related gene expression in macrophages within atherosclerotic plaques. Mechanistically, IR promoted cytoplasmic mtDNA release to activate the cGAS/STING/TBK1 axis and cause p‐IRF3 nuclear translocation. Phosphorylated IRF3 bound to the NLRP3 promoter and enhanced its transcription. Genetic ablation of caspase‐1 or macrophage‐specific cGAS knockdown alleviated IR‐driven AS progression. Conclusions and Implications: Macrophage pyroptosis drives IR‐accelerated AS progression through the mtDNA/cGAS/STING/p‐IRF3 axis‐dependent transcriptional up‐regulation of NLRP3. Targeting the cGAS‐STING pathway may provide a therapeutic strategy for IR‐associated atherosclerotic plaque progression.
- 13 November 2026
- Published by Wiley in British Journal of Pharmacology
Mitochondrial DNA‐cGAS‐STING induces macrophage pyroptosis via phospho‐IRF3‐mediated NLRP3 expression in ionising radiation‐induced atherosclerosis progression
Background and Purpose: Ionising radiation (IR) is a major cancer‐treatment modality, yet the mechanisms driving IR‐triggered cardiovascular injury are poorly defined. This work aimed to uncover how IR accelerates atherosclerosis (AS) and the underlying molecular mechanisms. Experimental Approach: We applied 9.4 T magnetic resonance imaging to evaluate atherosclerotic lesions. Single‐cell RNA sequencing was performed on carotid arteries. Apolipoprotein E (ApoE) knockout mice with caspase‐1 deletion and macrophage‐specific cGAS knockdown were used for in vivo validation. JASPAR prediction and dual‐luciferase reporter assays were implemented to verify transcriptional regulation of NLRP3. Key Results: IR substantially aggravated atherosclerotic progression, accompanied by elevated pyroptosis‐related gene expression in macrophages within atherosclerotic plaques. Mechanistically, IR promoted cytoplasmic mtDNA release to activate the cGAS/STING/TBK1 axis and cause p‐IRF3 nuclear translocation. Phosphorylated IRF3 bound to the NLRP3 promoter and enhanced its transcription. Genetic ablation of caspase‐1 or macrophage‐specific cGAS knockdown alleviated IR‐driven AS progression. Conclusions and Implications: Macrophage pyroptosis drives IR‐accelerated AS progression through the mtDNA/cGAS/STING/p‐IRF3 axis‐dependent transcriptional up‐regulation of NLRP3. Targeting the cGAS‐STING pathway may provide a therapeutic strategy for IR‐associated atherosclerotic plaque progression.
- Open Access
- 5 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (18) , e040632
Single‐Cell RNA Sequencing Reveals Granzyme K + CD8 + T Cells as a Target for Mitigating Plaque Instability Following Radiation
Background: Cardiac issues following radiotherapy are increasingly prevalent among patients with thoracic cancer and coronary disease. However, the mechanisms underlying radiotherapy‐induced plaque instability and changes in plaque characteristics on imaging remain unclear. This study used single‐cell RNA sequencing to identify key features of vulnerable plaques following radiotherapy. Methods: We applied dual‐mode synchronized optical coherence tomography‐intravascular ultrasound imaging in a rabbit model to reveal the characteristics of vulnerable plaques at various time points postradiotherapy. We then conducted single‐cell RNA sequencing on atherosclerotic lesions from A poE −/− (apolipoprotein E −/− ) mice across 3 stages: nonirradiated, early irradiation, and advanced irradiation. Bioinformatics was used to analyze cell populations, trajectories, and interaction differences among the groups. This was followed by pathological staining, flow cytometry, gene knockout, and antibody depletion. Results: In vivo optical coherence tomography‐intravascular ultrasound imaging at the initial stage accurately evaluated radiation exposure's effect on the stability of rabbit carotid plaques. High‐throughput single‐cell transcriptomics mapped the radiotherapy‐induced immune system remodeling in atherosclerotic lesions, and identified a granzyme K + CD8 + (cluster of differentiation 8 + ) T‐cell subpopulation. The infiltrating cells highly expressed the cytotoxic molecule GZMB (granzyme B) in the plaques. The absence of CD8 + T cells or GZMB ameliorated radiotherapy‐exacerbated atherosclerotic lesions. This demonstrates the pathogenic function of GZMK + (granzyme K + ) CD8 + cytotoxic T cells in promoting radiotherapy‐induced atherosclerotic lesion progression. Conclusions: We identified characteristic arterial imaging changes resulting from radiation injury, accurately and dynamically assessing the effects of radiation exposure on plaque stability. Radiation exposure affected plaque stability by modulating GZMK + CD8 + T‐cell activation and GZMB function, suggesting GZMB as a mediator of radio‐cardiovascular injury and a potential therapeutic target.
- 5 September 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (18) , e040632
Open AccessSingle‐Cell RNA Sequencing Reveals Granzyme K + CD8 + T Cells as a Target for Mitigating Plaque Instability Following Radiation
Background: Cardiac issues following radiotherapy are increasingly prevalent among patients with thoracic cancer and coronary disease. However, the mechanisms underlying radiotherapy‐induced plaque instability and changes in plaque characteristics on imaging remain unclear. This study used single‐cell RNA sequencing to identify key features of vulnerable plaques following radiotherapy. Methods: We applied dual‐mode synchronized optical coherence tomography‐intravascular ultrasound imaging in a rabbit model to reveal the characteristics of vulnerable plaques at various time points postradiotherapy. We then conducted single‐cell RNA sequencing on atherosclerotic lesions from A poE −/− (apolipoprotein E −/− ) mice across 3 stages: nonirradiated, early irradiation, and advanced irradiation. Bioinformatics was used to analyze cell populations, trajectories, and interaction differences among the groups. This was followed by pathological staining, flow cytometry, gene knockout, and antibody depletion. Results: In vivo optical coherence tomography‐intravascular ultrasound imaging at the initial stage accurately evaluated radiation exposure's effect on the stability of rabbit carotid plaques. High‐throughput single‐cell transcriptomics mapped the radiotherapy‐induced immune system remodeling in atherosclerotic lesions, and identified a granzyme K + CD8 + (cluster of differentiation 8 + ) T‐cell subpopulation. The infiltrating cells highly expressed the cytotoxic molecule GZMB (granzyme B) in the plaques. The absence of CD8 + T cells or GZMB ameliorated radiotherapy‐exacerbated atherosclerotic lesions. This demonstrates the pathogenic function of GZMK + (granzyme K + ) CD8 + cytotoxic T cells in promoting radiotherapy‐induced atherosclerotic lesion progression. Conclusions: We identified characteristic arterial imaging changes resulting from radiation injury, accurately and dynamically assessing the effects of radiation exposure on plaque stability. Radiation exposure affected plaque stability by modulating GZMK + CD8 + T‐cell activation and GZMB function, suggesting GZMB as a mediator of radio‐cardiovascular injury and a potential therapeutic target.
- Open Access
- 20 February 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 7 (8) , 2209-2221
Ultrasound-activated nano-oxygen sensitizer for sonodynamic–radiotherapy of esophageal cancer
Owing to the intricate nature, variability, and persistent oxygen-deficient environment associated with esophageal cancer tissues, radiotherapy sometimes doesn't work as well because some cancer cells can resist the radiation to a certain extent.
- 20 February 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 7 (8) , 2209-2221
Open AccessUltrasound-activated nano-oxygen sensitizer for sonodynamic–radiotherapy of esophageal cancer
Owing to the intricate nature, variability, and persistent oxygen-deficient environment associated with esophageal cancer tissues, radiotherapy sometimes doesn't work as well because some cancer cells can resist the radiation to a certain extent.
- 22 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 2) , 113418
Tricetin attenuates atherosclerosis by suppressing macrophage ferroptosis via activation of the NRF2 pathway
- 22 October 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 2) , 113418
Tricetin attenuates atherosclerosis by suppressing macrophage ferroptosis via activation of the NRF2 pathway
- Open Access
- 1 June 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-10
Sexual dimorphism in mitochondrial dysfunction and diabetes mellitus: evidence from a population-based cohort study
Background: Pathophysiological mechanisms underlying sex-based differences in diabetes remain poorly understood. Mitochondrial metabolite methylmalonic acid (MMA) accumulation reflects mitochondrial dysfunction which is involved in sex-specific pathophysiological responses biologically. We aimed to investigate the sex-specific associations between mortality risk and MMA in adults with the presence or absence of type 2 diabetes. Methods: This cohort study included 24,164 adults (12,123 females and 12,041 males) from the NHANES study during 1999–2014. Both sexes were separately categorized as those with no diabetes, prediabetes, undiagnosed diabetes, and diagnosed diabetes. Circulating MMA level was measured at baseline by mass-spectrometric detection. Mortality status was ascertained from baseline until December 31, 2015. Results: During a median follow-up of 11.1 years, 3375 deaths were documented. Males had a particularly higher mortality than females in adults with diagnosed diabetes compared to differences in those with no diabetes, prediabetes and undiagnosed diabetes (sex differences in mortality rate per 1000 person-years across diabetic status: 0.62, 1.44, 5.78, and 9.77, p < 0.001). Notably, the sex-specific difference in associations between MMA and mortality was significant only in adults with diagnosed diabetes (p for interaction = 0.028), not in adults with no diabetes and prediabetes. Adjusted HRs (95%CIs) per doubling of MMA for all-cause mortality were 1.19 (1.04–1.37) in females with diagnosed diabetes versus 1.58 (1.36–1.86) in male counterparts. In addition, MMA levels had an insignificant or weak correlation with sex hormone profiles at baseline, regardless of diabetes status and sex. Conclusions: Sex difference in mortality risk was especially significant in diagnosed type 2 diabetes. Increasing equivalent exposure to mitochondrial metabolite MMA was associated with a greater excess risk of future mortality in males with diabetes than in females.
- 1 June 2023
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 15 (1) , 1-10
Open AccessSexual dimorphism in mitochondrial dysfunction and diabetes mellitus: evidence from a population-based cohort study
Background: Pathophysiological mechanisms underlying sex-based differences in diabetes remain poorly understood. Mitochondrial metabolite methylmalonic acid (MMA) accumulation reflects mitochondrial dysfunction which is involved in sex-specific pathophysiological responses biologically. We aimed to investigate the sex-specific associations between mortality risk and MMA in adults with the presence or absence of type 2 diabetes. Methods: This cohort study included 24,164 adults (12,123 females and 12,041 males) from the NHANES study during 1999–2014. Both sexes were separately categorized as those with no diabetes, prediabetes, undiagnosed diabetes, and diagnosed diabetes. Circulating MMA level was measured at baseline by mass-spectrometric detection. Mortality status was ascertained from baseline until December 31, 2015. Results: During a median follow-up of 11.1 years, 3375 deaths were documented. Males had a particularly higher mortality than females in adults with diagnosed diabetes compared to differences in those with no diabetes, prediabetes and undiagnosed diabetes (sex differences in mortality rate per 1000 person-years across diabetic status: 0.62, 1.44, 5.78, and 9.77, p < 0.001). Notably, the sex-specific difference in associations between MMA and mortality was significant only in adults with diagnosed diabetes (p for interaction = 0.028), not in adults with no diabetes and prediabetes. Adjusted HRs (95%CIs) per doubling of MMA for all-cause mortality were 1.19 (1.04–1.37) in females with diagnosed diabetes versus 1.58 (1.36–1.86) in male counterparts. In addition, MMA levels had an insignificant or weak correlation with sex hormone profiles at baseline, regardless of diabetes status and sex. Conclusions: Sex difference in mortality risk was especially significant in diagnosed type 2 diabetes. Increasing equivalent exposure to mitochondrial metabolite MMA was associated with a greater excess risk of future mortality in males with diabetes than in females.
- 20 April 2023
- Published by Elsevier in Atherosclerosis
- Vol. 378, 117118
Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history
- 20 April 2023
- Published by Elsevier in Atherosclerosis
- Vol. 378, 117118
Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history